直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Article

Expanding Standards of Inequitable Conduct: Increased Burden of Disclosure on Patent Applicants

July 2010

AIPPI Journal

By Ming-Tao Yang

This article by Finnegan attorneys James W. Edmonson and Ming-Tao Yang, and Raymond M. Gabriel,  discusses the recent decisions from the Federal Circuit that have left the impression that it is becoming easier to succeed on an inequitable conduct defense, which renders patents, not just certain claims, unenforceable. They state that these decisions have found inequitable conduct based on omission by a non-inventor corporate president and contradictory statements made in foreign prosecution. Edmonson, Yang, and Gabriel examine two cases, Avid Identification Sys., Inc. v. Crystal Imp. Corp., 603 F.3d 967 (Fed. Cir. 2010) and Therasense, Inc. v. Becton, Dickinson & Co., 593 F.3d 1289 (Fed. Cir. 2010), as examples of an increased burden on patent applicants. Under Avid, applicants should take a broad view on who is substantively involved in prosecution and shield non-inventor corporate actors from prosecution. Under Therasense, applicants must facilitate communications between U.S. and non-U.S. prosecution counsel or bring foreign prosecution statements to the U.S. counsel's attention. However, they state that the Federal Circuit's recent order to rehear Therasense en banc, indicates that it could modify the current standard. The authors close with a word of caution that until the current standard is modified, applicants operating under the current law and these decisions need to understand who is subject to the duty of disclosure and what needs to be disclosed.

Related Professionals

Ming-Tao Yang
Partner
Palo Alto, CA
+1 650 849 6783
Email

Related Insights

Conference

2027 ABA-IPL Section Annual Meeting – IPLSPRING

April 14-15, 2027

Arlington

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Webinar

Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe

November 19, 2026

Webinar

Conference

IPBC Asia 2026

November 17-19, 2026

Tokyo

Conference

NAPABA Convention 2026

November 12-14, 2026

Los Angeles

Conference

IAM Live: Trade Secret Strategy USA

November 10, 2026

San Jose

Charitable

2026 ALYN Hospital Wheels of Love Ride

November 8-12, 2026

Northern District

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP